Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antibiotic   Gentamicin sulfate  
Injection
Eye-drops
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Amplomicina Brazil
Azupel Peru
Cidomycin Egypt, Great Britain, Ireland
Dabroson Greece
Epigent Egypt
Garalone Portugal
Garamicina Brazil
Garamycin Croatia, Denmark, Egypt, Greece, Norway, Republic of South Africa, Slovenia, Sweden, Switzerland, Turkey
Gencin Germany
Genmisin Turkey
Gensif Turkey
Gensumycin Finland, Norway, Sweden
Genta Turkey
Genta-Gobens Spain
Gentalline France
Gentamen Italy
Gentamival Spain
Gentaplus Brazil
Genticin Great Britain
Gentomil Italy
Gentreks Turkey
Geomycine Belgium
Getamisin Turkey
Gevramycin Spain
Hexamycin Denmark
Plurisemina Argentina
Refobacin Austria, Germany
Regaminol Egypt
Rupegen Argentina
Stability in solutions   Injection   Stability in solutions : Gentamicin sulfate     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 10 mg/ml 4°C Protect from light
84 Day
1486
Biological analysis
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml -20°C Protect from light
30 Day
573
Biological analysis
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 4°C Protect from light
48 Hour
434

Polyvinyl chloride NaCl 0,9% or Glucose 5% 1,2 mg/ml -20°C Protect from light
28 Day
565
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 1 mg/ml 25°C Light
48 Hour
434

Polyvinyl chloride Glucose 5% 1 mg/ml 25°C Light
48 Hour
434

Conflicting data
Polyvinyl chloride Glucose 5% 1,6 mg/ml -20°C Protect from light
30 Day
576
Biological analysis
Polyvinyl chloride Extraneal® (Baxter) 0,02 mg/ml 25°C Protect from light
14 Day
3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0,02 mg/ml 37°C Protect from light
14 Day
3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0,02 mg/ml 4°C Protect from light
14 Day
3888
Level of evidence D
Polyethylene Water for Injection 2,5 mg/ml 25°C With or without light
112 Day
3141
Level of evidence B
Ethylene vinyl acetate Sodium chloride 0,9% 0,85 mg/ml 23°C Protect from light
7 Day
1704
Level of evidence A+
Ethylene vinyl acetate Sodium chloride 0,9% 0,85 mg/ml 4°C Protect from light
30 Day
1704
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 30 mg/ml 22°C-23°C Light
48 Hour
639
Level of evidence D
Polyisoprene elastomer NaCl 0,9% or Glucose 5% 0,5 & 5 mg/ml 4°C Protect from light
10 Day
604
Manufacturer's stability data
Polyisoprene elastomer Sodium chloride 0,9% 0,5 & 5 mg/ml 25°C Not specified
24 Hour
604
Manufacturer's stability data
Polyisoprene elastomer Glucose 5% 0,5 & 5 mg/ml 25°C Not specified
24 Hour
604
Manufacturer's stability data
Conflicting data
Not specified Water for Injection 2,5 mg/ml 37°C Not specified
96 Hour
3952
Level of evidence A
  Mentions Légales